Feb 10 (Reuters)-
RaQualia Pharma Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2016 Dec 31, 2015 Dec 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 705 mln 145 mln 1.10
(+384.7 pct) (-5.5 pct) (+56.0 pct)
Operating loss 759 mln loss 1.86 loss 760 mln
Recurring loss 720 mln loss 1.80 loss 761 mln
Net loss 728 mln loss 1.85 loss 767 mln
EPS loss 38.80 yen loss 116.45 yen loss 40.91 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T
((Tokyo Headline News Desk +813 6441 1812))